FindMyKOL
Clinical trialNCT01270620CompletedPhase 4Interventional

Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement

NCT01270620 is a phase 4 interventional trial sponsored by Pedro Paulo Tanaka. As of 18 Nov 2026, it is completed. It studies Desflurane and Propofol in Arthritis and Obesity. The registry lists an enrollment of 100 participants at 1 site in 1 country. The registry lists a start date of 31 Dec 2010 and a primary completion date of 31 Jul 2015.

SponsorPedro Paulo TanakaEnrollment100ArthritisObesity
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01270620
FieldValue
Registry IDNCT01270620
StatusCompleted
PhasePhase 4
Study typeInterventional trial
Lead sponsorPedro Paulo Tanaka
Enrollment100
Registered sites1
Countries1
ConditionsArthritis and Obesity
DrugsDesflurane and Propofol
Start31 Dec 2010
Primary completion31 Jul 2015
Study completion31 Jul 2015
Last update posted22 Oct 2015

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

You are invited to participate in a research study assessing your mental status in the first days after your surgery and how you will be doing in the 2 years following the surgery. The investigators hope to learn more about the incidence of postoperative confusion and a possible relation with 2 anesthesia techniques that are routinely used. The first one is an anesthesia technique that uses the inhaled anesthetic gas desflurane and the second one is an anesthesia technique that uses the anesthetic propofol administered by infusion in a vein. The investigators are also looking to see if there is a relationship between anesthesia technique and cardiovascular outcomes. You were selected as a possible participant in this study because at your age this phenomenon appears to have a greater incidence.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Stanford University School of Medicine

    Stanford

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DesfluranePropofol →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT01270620

Each answer restates registry values shown on this page.

What is NCT01270620?

NCT01270620 is a phase 4 interventional trial sponsored by Pedro Paulo Tanaka. It studies Desflurane and Propofol in Arthritis and Obesity.

Who leads NCT01270620?

The registry names Hendrikus Lemmens (principal investigator, Stanford University) and Pedro Paulo Tanaka (study director, Stanford University) as overall officials.

Where does NCT01270620 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT01270620 study?

The registered drug and biological interventions are Desflurane and Propofol.

When did NCT01270620 end?

The registry lists a primary completion date of 31 Jul 2015 and a study completion date of 31 Jul 2015. The sponsor last updated the record on 22 Oct 2015.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.